Too Many Biotechnology Bargains: Which Is The Best Bet For 2013?
News | 20 February 2013
There are many articles on Seeking Alpha on the biotechnology companies -- Vivus Inc. (VVUS), Amgen Inc. (AMGN), Novo Nordisk A/S (NVO), Gilead Sciences Inc. (GILD) and Celgene Corporation (CELG). They have a very similar story to tell. They are ...
Click on the link to read the full article at Seeking Alpha
(This link will open in a new window)
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
